Basking Biosciences, Inc.
Clinical trials sponsored by Basking Biosciences, Inc., explained in plain language.
-
New stroke drug enters Mid-Stage human testing
Disease control Recruiting nowThis study is testing a new drug called BB-031 for people who have just had a stroke caused by a blood clot. The main goals are to see if the drug is safe and how the body processes it. About 228 participants will receive either the study drug or a placebo and be monitored for 90…
Phase: PHASE2 • Sponsor: Basking Biosciences, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
First human tests begin for new drug combination
Knowledge-focused Recruiting nowThis is an early safety study testing a new drug called BB-025, both by itself and after another drug called BB-031. The main goal is to see how safe these drugs are and how they move through the body in 72 healthy volunteers. Participants will be monitored for 28 days to check f…
Phase: PHASE1 • Sponsor: Basking Biosciences, Inc. • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC